Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
56 studies found for:    Open Studies | "Poisoning"
Show Display Options
Rank Status Study
1 Recruiting Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning
Condition: Neuropsychiatric Sequelae of Carbon Monoxide Poisoning
Intervention: Drug: HBOT
2 Recruiting Treatment of Human Cord Blood Mononuclear Cell for Delayed Encephalopathy After Carbon Monoxide Poisoning
Condition: Delayed Encephalopathy After Carbon Monoxide Poisoning
Interventions: Biological: Human cord blood mononuclear cell;   Other: hyperbaric oxygen
3 Recruiting Role of Pulse Co-oximetry for Detecting Carbon Monoxide Poisoning in the Prehospital Emergency Medical Service Setting
Condition: Carbon Monoxide Poisoning
Interventions: Device: RAD57 measurement (SpCO);   Device: CO-oximeter
4 Not yet recruiting Occult Carbon Monoxide Poisoning Detection by Pulsated Carboxymetry in an Emergency Department
Condition: Carbon Monoxide Poisoning
Intervention: Device: Dosage of the blood HbCO thanks to the carboxymeter MASIMO RAD 57
5 Recruiting Normal Quantitative EEG (qEEG) Dataset
Condition: Carbon Monoxide Poisoning
Intervention: Procedure: Electroencephalography
6 Recruiting Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Paraquat Poisoning Induced Lung Injury
Conditions: Paraquat Poisoning;   Lung Injury
Interventions: Biological: UCMSC group;   Other: Control group(Normal saline)
7 Not yet recruiting Suspected Cases of Carbon Monoxide Poisoning
Condition: Carbon Monoxide Intoxication
Intervention: Device: Observational data collection.
8 Recruiting Selenium and Arsenic Pharmacodynamics
Condition: Arsenic Poisoning Chronic
Interventions: Dietary Supplement: Anhydrous selenite;   Dietary Supplement: Sodium chloride
9 Recruiting Effect of Folic Acid on Skin Fungal Pattern in Patients With Arsenicosis
Condition: Chronic Arsenic Poisoning
Interventions: Drug: Iron 200 mg;   Drug: Folic acid 5 mg
10 Not yet recruiting ID Recombinant Ricin Toxin A-Chain Vaccine RVEc™ — 3-Dose Primary Series With Boost
Condition: Ricin Poisoning
Intervention: Biological: RVEc
11 Not yet recruiting IM Recombinant Ricin Toxin Vaccine (RVEc) — 3-Dose Primary Series With Boost
Condition: Ricin Poisoning
Intervention: Biological: RVEc
12 Recruiting Specified Drug-use Survey of Fomepizole Intravenous Infusion (All-case Surveillance)
Condition: Ethylene Glycol Poisoning, Methanol Poisoning
Intervention: Drug: Fomepizole
13 Recruiting Intravenous Milk Thistle (Silibinin-Legalon) for Hepatic Failure Induced by Amatoxin/Amanita Mushroom Poisoning
Conditions: Amatoxin Poisoning;   Amanita Poisoning;   Mushroom Poisoning;   Liver Failure
Intervention: Drug: Silibinin
14 Not yet recruiting Alpha Lipoic Acid as an Adjuvant Treatment in Acute Phosphide Poisoning
Condition: Toxicity
Interventions: Drug: Alpha Lipoic Acid (Thioctacid);   Drug: Placebo (for Alpha Lipoic Acid)
15 Not yet recruiting Mannitol Versus Supportive Care in Ciguatera Fish Poisoning
Condition: Ciguatoxin
Intervention: Drug: Mannitol
16 Recruiting Repeated Voluntary Drug Intoxication (IMVr): Characterization of a New Addictive Behavior by Clinical Phenotyping and Functional Imaging
Conditions: Volunteers Repeated Drug Poisoning;   Alcoholic;   Volunteers
Intervention: Other: MRI and biological assessment
17 Recruiting Sevoflurane- Safety in Long-term Sedation Procedures
Conditions: Poisoning by Inhaled Anaesthetic;   Fluoride Poisoning;   Recovery From Sedation;   Renal Function;   Hepatic Function
Interventions: Drug: Sevoflurane;   Drug: Midazolam
18 Not yet recruiting Action of Infiltration Resin Icon in Fluorosis, Clinical Trial, Monitoring for 12 Month
Conditions: Fluorosis;   Oral Deseases
Interventions: Device: Resin Infiltration;   Procedure: Microabrasion
19 Not yet recruiting Prolonged Gadolinium Retention After MRI Imaging
Condition: Heavy Metal Toxicity
Intervention: Drug: edetate calcium disodium
20 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.